Predictive value of PD-L1 expression in response to immune checkpoint inhibitors for gastric cancer treatment: a systematic review and meta-analysis.
Maryam NooriFarimah FayyazMohammad Reza ZaliSoroush SadeghiPublished in: Expert review of anticancer therapy (2023)
Among patients suffering from gastric cancer, considering PD-L1 CPS thresholds seems to be a more reliable predictive factor than TPS threshold for lower rate of mortality when PD-1/PD-L1 inhibitors are administrated.